GEN vs ZYME · P/E 17, rev $5.00B vs rev $76.3M
Gen Digital Inc. (GEN) versus Zymeworks Inc. Common Stock (ZYME) — a side-by-side from cached financials, not a winner call.
Gen Digital Inc. (GEN) is a software - infrastructure company listed on US.
Zymeworks Inc. Common Stock (ZYME) is a biotechnology company listed on NASDAQ.
Latest reported GEN revenue for 2026-04-03 was $5.00B. Net income was $973.0M. Revenue was up 27.1% from 2025-03-28 to 2026-04-03. GEN currently screens at market cap $15.83B and trailing P/E 16.7.
Latest reported ZYME revenue for 2024-12-31 was $76.3M. Net income was -$122.7M. Revenue was up 0.4% from 2023-12-31 to 2024-12-31. ZYME currently screens at market cap $1.68B.
GEN currently screens at market cap $15.83B and trailing P/E 16.7. ZYME currently screens at market cap $1.68B.
Not investment advice. Open the GEN and ZYME stock pages for the full models.
Not investment advice.